Incidence of intraoperative hypoxemia in children in relation to age

Jurgen C de Graaff1, Jilles B Bijker, T H Kappen

  • 1Department of Pediatric Anesthesia, Wilhelmina Children's Hospital, Division of Anesthesiology, Intensive Care and Emergency Medicine, Q04.2.313, University Medical Center Utrecht, PO box 85500, 3508 GA Utrecht, the Netherlands. j.c.degraaff-2@umcutrecht.nl

Insights

Pediatric anesthesia can cause hypoxemia, with true incidence data lacking. A study found significant intraoperative hypoxemia in children, especially neonates, but cautioned that many recorded events are artifacts.

Area of Science:

  • Anesthesiology
  • Pediatric Critical Care
  • Respiratory Physiology

Background:

  • Respiratory problems are common complications in pediatric anesthesia.
  • Reliable data on perioperative hypoxemia incidence in children are scarce.
  • Previous studies often relied on self-reported data for respiratory complications.

Purpose of the Study:

  • To determine the incidence of intraoperative hypoxemia in pediatric patients.
  • To assess the rate of pulse oximeter artifacts during pediatric anesthesia.
  • To analyze age-related differences in hypoxemia incidence.

Main Methods:

  • Prospective study of 575 pediatric noncardiac surgery patients (0-16 years).
  • Retrospective analysis of 8277 patients from an anesthesia information management system (AIMS).
  • Monitoring of oxygen saturation (SpO2) and identification of true hypoxemic events versus artifacts.

Main Results:

  • In the prospective cohort, 12% experienced SpO2 ≤ 90% for ≥ 1 minute, with 6% having true hypoxemia.
  • Retrospective analysis showed SpO2 ≤ 90% in 18% and SpO2 ≤ 80% in 7.5% of cases.
  • Hypoxemia incidence increased with younger age, reaching 56% in neonates (SpO2 ≤ 90%).

Conclusions:

  • Intraoperative hypoxemia is more frequent in younger children, particularly neonates.
  • A high rate of pulse oximeter artifacts (up to 35%) necessitates cautious interpretation of unvalidated AIMS data.
  • Only up to 65% of recorded hypoxemic episodes during pediatric anesthesia represent true hypoxia.
Abstract

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Hypoxia01:23

Hypoxia

Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Respiratory Assessment: Purpose and Indications01:19

Respiratory Assessment: Purpose and Indications

Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...